Jubilant Pharmova Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the transcript of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on Tuesday, August 2, 2022. This is for your information and records.

pdf

Jubilant Pharmova Ltd.

02 Aug 2022

1106.00

3.33%

Results Earnings Call for Q1FY23 of Jubilant Pharmova

Conference Call with Jubilant Pharmova Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

Jubilant Pharmova Ltd.

02 Aug 2022

1106.00

3.33%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

we wish to inform that audio recording of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 held on Tuesday, August 2, 2022, has been uploaded on the Company''s website and same is given in the attached letter.

pdf

Jubilant Pharmova Ltd.

02 Jun 2022

1106.00

3.33%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the earnings conference call for the quarter and year ended March 31, 2022

pdf

Jubilant Pharmova Ltd.

28 May 2022

1106.00

3.33%

Earnings Call for Q4FY22 of Jubilant Pharmova

Conference Call with Jubilant Pharmova Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

Jubilant Pharmova Ltd. Conference Calls and Earnings Call Transcripts